Q413299: Difference between revisions

@@ label / zh-hk / label / zh-hk @@
-安維汀
@@ label / zh-sg / label / zh-sg @@
-安维汀
@@ label / zh-tw / label / zh-tw @@
-安維汀
@@ label / ru / label / ru @@
-Бевацизумаб
+бевацизумаб
@@ label / nb / label / nb @@
+bevacizumab
@@ aliases / zh / 0 / aliases / zh / 0 @@
+安维汀®
@@ aliases / zh / 1 / aliases / zh / 1 @@
+癌思停®
@@ aliases / zh / 2 / aliases / zh / 2 @@
+达攸同®
@@ aliases / zh / 3 / aliases / zh / 3 @@
-癌思停
@@ aliases / zh / 4 / aliases / zh / 4 @@
-安维汀
@@ aliases / zh / 5 / aliases / zh / 5 @@
-达攸同
@@ description / zh / description / zh @@
+药物
@@ Property / DrugBank ID @@
@@ Property / DrugBank ID: 00112 / rank @@
-Normal rank
@@ Property / DrugBank ID: 00112 / reference @@
-stated in: DrugBank
DrugBank ID: 00112
language of work or name: English
title: Bevacizumab (English)
publication date: 17 November 2015Timestamp +2015-11-17T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2015-11-17T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / DrugBank ID: 00112 / reference @@
-reference URL: https://www.drugbank.ca/releases/latest#open-data
retrieved: April 2018Timestamp +2018-04-24T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 month
Before 0
After 0
-Timestamp
++2018-04-24T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+month
 Before
 After
@@ Property / DrugBank ID @@
+DB00112
@@ Property / DrugBank ID: DB00112 / rank @@
+Normal rank
@@ Property / medical condition treated @@
+low-grade serous carcinoma
@@ Property / medical condition treated: low-grade serous carcinoma / rank @@
+Normal rank
@@ Property / medical condition treated: low-grade serous carcinoma / reference @@
+reference URL: https://cureourovariancancer.org/wp-content/uploads/2019/08/NCCN-ovarian.pdf